Nutriband Inc stock is traded at $5.41, with a volume of 3,466. It is down -2.96% in the last 24 hours and down -19.01% over the past month. Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
Previous Close:
$5.58
Open:
$5.46
24h Volume:
3,466
Relative Volume:
0.14
Market Cap:
$65.76M
Revenue:
$1.80M
Net Income/Loss:
-$8.08M
P/E Ratio:
-
EPS:
-$2.63
Net Cash Flow:
-$4.36M
1W Performance:
-14.13%
1M Performance:
-19.01%
6M Performance:
+36.27%
1Y Performance:
-2.17%
1-Day Range:
$5.41$5.79
1-Week Range:
$5.28$6.52
52-Week Range:
$2.80$9.19
Nutriband Inc Stock (NTRB) Company Profile
Name
Nutriband IncSector
HealthcareIndustry
BiotechnologyPhone
407 377-6695Address
121 S. ORANGE AVE., ORLANDO, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS